announced today that its work entitled "Decreased CRP levels in response to a six-week, once-daily oral insulin regimen" will be presented at the XVI International Symposium on Atherosclerosis (ISA2012) on March 25-29, 2012, to be held in Sydney,
How smoking could contribute to angina and heart disease.
We aimed to ascertain the associations of clinical obesity measures with metabolic cardiovascular risk and atherosclerosis in African women with RA from a developing black and developed Caucasian population.
IRVINE, Calif., March 21, 2012 /PRNewswire via COMTEX/ — AtheroNova Inc. (OBB:AHRO) , a biotech company focused on the research and development of compounds to regress atherosclerotic plaque, today announced that it has released financial results for
March 20, 2012 (San Diego, California) — A novel oral immune modulator, known as VB-201, simultaneously improved psoriatic skin lesions and reduced atherosclerotic plaque in a phase 2 study, according to results reported here at the American Academy